Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Squamous Cell Carcinoma of Head and Neck × Erlotinib Hydrochloride × 30 days × Clear all

Sponsor

Conditions

Pancreatic Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Papillary renal cell carcinoma, sporadic 1 Pancreatic Intraductal Neoplasms 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Lung Neoplasms 1 Hereditary leiomyomatosis and renal cell cancer 1 Carcinoma, Renal Cell 1 Adult Solid Neoplasm 1

Interventions

pembrolizumab 26 Cisplatin 21 Cetuximab 19 Carboplatin 18 Magnetic Resonance Spectroscopy 12 Specimen Handling 11 Radiotherapy, Intensity-Modulated 11 Paclitaxel 8 Radiotherapy 7 Platinum 7 Nivolumab 7 Fluorouracil 7 Docetaxel 7 1,2-diaminocyclohexaneplatinum II citrate 7 Biopsy 6 (225)Ac-DOTA-c(RGDyK) 5 Ipilimumab 4 atezolizumab 3 Taxes 3 Radiosurgery 3 Immunoglobulin G 3 Fulvestrant 3 Drug Therapy 3 Bevacizumab 3 zimberelimab 2 toripalimab 2 dehydroftorafur 2 cemiplimab 2 Surgical Procedures, Operative 2 Radiation 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡